Iijima, Yuki
Ejima, Masaru
Yamana, Takashi
Sonoda, Shiro
Shibata, Sho
Shirai, Tsuyoshi
Okamoto, Tsukasa
Furusawa, Haruhiko
Tateishi, Tomoya
Adachi, Takuya
Mori, Mio
Kirimura, Susumu
Anzai, Tatsuhiko
Takahashi, Kunihiko
Miyazaki, Yasunari
Article History
Received: 26 July 2023
Accepted: 4 January 2024
First Online: 14 February 2024
Declarations
:
: The study protocol was approved by the Ethics Committee of Tokyo Medical and Dental University (approval number M2019-206). Informed consent was waived by Ethics Committee of Tokyo Medical and Dental University because of the retrospective nature of the study.
: Not applicable.
: Dr. Yuki Iijima reports grants from Japan Society for the Promotion of Science. Dr.Tsukasa Okamoto reports endowment from Nippon Boehringer Ingelheim Co., Ltd. Dr. Yasunari Miyazaki reports grants from Nippon Boehringer Ingelheim Co., Ltd. and Chugai Pharmaceutical Co., Ltd., and personal fees from Nippon Boehringer Ingelheim Co., Ltd. and AstraZeneca K.K., outside the submitted work. The remaining authors have no disclosures.